Eliem Therapeutics Announces $60 Million Series B Financing

Advances two clinical programs through topline data across four indications Progresses two preclinical programs to potential lead candidate selection Brings total funding since inception to $140 million SEATTLE and CAMBRIDGE, England, May 24, 2021... Biopharmaceuticals, Neurology, Venture Capital Eliem Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news